This Morning's Technical Outlook on Services Stocks -- Myriad Genetics, QIAGEN, WillScot, and H&R Block
NEW YORK, Feb. 15, 2018 /PRNewswire/ --WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on MYGN, QGEN, WSC, and HRB which can be accessed for free by signing up to www.wallstequities.com/registration. On Wednesday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the trading session up 1.86%; the Dow Jones Industrial Average edged 1.03% higher; and the S&P 500 was up 1.34%. US markets made broad based gains with eight out of nine sectors finishing the day in green. Pre-market today, WallStEquities.com reviews these four Services stocks: Myriad Genetics Inc. (NASDAQ: MYGN), QIAGEN N.V. (NYSE: QGEN), WillScot Corp. (NASDAQ: WSC), and H&R Block Inc. (NYSE: HRB). All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
Myriad Genetics
Salt Lake City, Utah headquartered Myriad Genetics Inc.'s stock finished Wednesday's session 1.97% higher at $33.70. A total volume of 686,277 shares was traded. The Company's shares have advanced 97.89% in the last twelve months. The stock is trading above its 200-day moving average by 12.29%. Furthermore, shares of Myriad Genetics, which focuses on developing and marketing novel predictive medicine, personalized medicine, and prognostic medicine tests worldwide, have a Relative Strength Index (RSI) of 42.18.
On January 29(th), 2018, research firm Goldman initiated a 'Sell' rating on the Company's stock, with a target price of $32 per share. Get the full research report on MYGN for free by clicking below at:
www.wallstequities.com/registration/?symbol=MYGN
QIAGEN
Shares in Venlo, the Netherlands headquartered QIAGEN N.V. ended at $33.03, up 3.19% from the last trading session. The stock recorded a trading volume of 1.07 million shares. The Company's shares have gained 13.78% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 2.43% and 1.05%, respectively. Moreover, shares of QIAGEN, which provides sample to insight solutions that transform biological materials into molecular insights worldwide, have an RSI of 53.56.
On January 29(th), 2018, research firm Goldman initiated a 'Buy' rating on the Company's stock, with a target price of $39 per share. QGEN's complimentary research coverage is a few simple steps away at:
www.wallstequities.com/registration/?symbol=QGEN
WillScot
Baltimore, Maryland headquartered WillScot Corp.'s stock ended yesterday's session flat at $12.30 with a total trading volume of 138,807 shares. The Company's shares have advanced 23.00% over the previous three months and 23.62% in the last twelve months. The stock is trading above its 200-day moving average by 15.87%. Additionally, shares of WillScot, which through its subsidiaries, provides various specialty rental services in the US, Canada, and Mexico, have an RSI of 47.84.
On January 23(rd), 2018, research firm Deutsche Bank initiated a 'Buy' rating on the Company's stock. Are you already registered with Wall St. Equities? Do so now for free, and get the report on WSC at:
www.wallstequities.com/registration/?symbol=WSC
H&R Block
On Wednesday, shares in Kansas City, Missouri headquartered H&R Block Inc. recorded a trading volume of 3.55 million shares, which was above their three months average volume of 3.03 million shares. The stock finished the day 3.98% higher at $26.94. The Company's shares have advanced 28.47% over the last twelve months. The stock is trading above its 50-day moving average by 1.55%. Furthermore, shares of H&R Block, which through its subsidiaries, provides assisted income tax return preparation, digital DIY tax solutions, and other services and products related to income tax return preparation to the general public primarily in the US, Canada, and Australia, have an RSI of 56.89. Aspiring Member, please take a moment to register below for your free research report on HRB at:
www.wallstequities.com/registration/?symbol=HRB
--
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
https://wallstequities.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@wallstequities.com
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
View original content:http://www.prnewswire.com/news-releases/this-mornings-technical-outlook-on-services-stocks----myriad-genetics-qiagen-willscot-and-hr-block-300599353.html
SOURCE Wall St. Equities
